Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the International Kidney Cancer Symposium North America 2025 think tank

Study limitation reported by the research below: “No patient-level clinical outcome data are reported; this is an expert consensus document, not an interventional study.”